Literature DB >> 975048

Stimulated DNA synthesis in mouse epidermal cell cultures treated with 12-O-tetradecanoyl-phorbol-13-acetate.

S H Yuspa, T Ben, E Patterson, D Michael, K Elgjo, H Hennings.   

Abstract

Exposure of mouse epidermal cells in culture to 12-O-tetradecanoyl-phorobol-13-acetate (TPA) results in an initial inhibition of DNA synthesis for 24 hr followed by a 5- to 10-fold stimulation at 72 to 96 hr. A corresponding increase in mitotic rate also occurs at 72 to 96 hr. These responses occur when TPA is continuously present in the medium or if the exposure is as short as 1 hr, but the degree of stimulation was dependent on dose and duration of exposure. Sensitivity to TPA varied with the length of time the cells were in culture prior to treatment. TPA treatment also produced an alteration in morphology from clearly epithelial to a more fibroblastic type. These biochemical and morphological effects did not occur after treatment of epidermal cells with either phorbol-13,20-diacetate or phorbol. Primary dermal fibroblasts in culture did not respond to TPA in this manner, but a line of cultured liver epithelial cells was slightly stimulated by the promoter. This system appears to be a sensitive in vitro model for detecting the hyperplasia-inducing effects of phorbol esters and should be used for mechanistic studies and bioassay.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 975048

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Induction of endogenous xenotropic retrovirus expression by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.

Authors:  W A Suk; C W Long
Journal:  In Vitro Cell Dev Biol       Date:  1986-05

2.  Antagonistic effect of selenite on tumor promoter induced cell proliferation in cultures of rat tongue epithelium.

Authors:  D Arenholt-Bindslev; B Larsen; M Abdulla; A Jepsen
Journal:  Biol Trace Elem Res       Date:  1988 Jan-Apr       Impact factor: 3.738

3.  Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts.

Authors:  P Angel; A Pöting; U Mallick; H J Rahmsdorf; M Schorpp; P Herrlich
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

4.  The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.

Authors:  Senthil Nathan Arun; Ding Xie; M Ernest Dodd; Xiaofeng Zhong; Wendy B Bollag
Journal:  J Dermatol Sci       Date:  2010-08-10       Impact factor: 4.563

5.  Comparison of differentiation patterns in 12-O-tetradecanoylphorbol-13-acetate-treated epidermis and fetal epidermis.

Authors:  M Chiba; C M Taylor; A J Klein-Szanto
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  Phorbol esters potentiate tyrosine phosphorylation of epidermal growth factor receptors in A431 membranes by a calcium-independent mechanism.

Authors:  S O Moon; H C Palfrey; A C King
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Improved conditions for murine epidermal cell culture.

Authors:  S M Fischer; A Viaje; K L Harris; D R Miller; J S Bohrman; T J Slaga
Journal:  In Vitro       Date:  1980-02

8.  Mitogenic effect of 12-0 tetradecanoyl phorbol 13-acetate on non-human primate mononuclear cells and in vitro interaction with Epstein-Barr virus transformation.

Authors:  S K Sundar; D V Ablashi; Z H Bengali; P H Levine; M Nonoyama
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

9.  Specific quantification of mouse and human keratin proteins by radioimmunoassay.

Authors:  S H Yuspa; M C Poirier; J R Harness; D R Olsom; P M Steinert
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

10.  Primary dermal fibroblasts derived from sdc-1 deficient mice migrate faster and have altered alphav integrin function.

Authors:  Rosalyn A Jurjus; Yueyuan Liu; Sonali Pal-Ghosh; Gauri Tadvalkar; Mary Ann Stepp
Journal:  Wound Repair Regen       Date:  2008 Sep-Oct       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.